CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dong Wook Shin, Dae Jung Kim
Diabetes Metab J. 2021;45(2):251-259.   Published online March 5, 2021
DOI: https://doi.org/10.4093/dmj.2020.0206

Excel Download

Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19
Diabetes & Metabolism Journal. 2021;45(2):251-259   Crossref logo
Link1 Link2 Link3

From confusion to clarity: RAS blockade in patients hospitalized with COVID-19
Kidney International. 2021;   Crossref logo
Link1 Link2

Characteristics and outcomes of COVID-19 positive patients with diabetes managed as outpatients
Diabetes Research and Clinical Practice. 2020;164:108229   Crossref logo
Link1 Link2

Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on m
Diabetes, Obesity and Metabolism. 2017;19(3):394-400   Crossref logo
Link1 Link2

Comparative analysis of quality of life in patients treated with canagliflozine or DPP-IV inhibitor
Diabetes mellitus. 2016;19(6):511-517   Crossref logo
Link1 Link2

Dipeptidyl peptidase-4 (DPP-4) inhibitor and mortality in coronavirus disease 2019 (COVID-19) – A systematic review, meta-analysis, and meta-regression
Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(3):777-782   Crossref logo
Link1 Link2

Heart failure outcomes and Covid-19
Diabetes Research and Clinical Practice. 2021;108794   Crossref logo
Link1 Link2

DPP-4 inhibition and COVID-19: From initial concerns to recent expectations
Diabetes & Metabolism. 2021;47(2):101213   Crossref logo
Link1 Link2

Comparable COVID ‐19 outcomes with current use of GLP ‐1 receptor agonists, DPP ‐4 inhibitors or SGLT ‐2 inhibitors among patients with diabetes who tested positive for SARS‐CoV ‐2
Diabetes, Obesity and Metabolism. 2021;   Crossref logo
Link1 Link2 Link3

Corrigendum to Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States
Journal of Diabetes Science and Technology. 2020;193229682093267   Crossref logo
Link1 Link2 Link3